Journal of Clinical and Experimental Ophthalmology
Open Access

Preparing and obtaining quality compounded ophthalmic preparations

4^th International Conference on Clinical & Experimental Ophthalmology

July 14-16, 2014 DoubleTree by Hilton Baltimore-BWI Airport, USA

Linda F. McElhiney

Scientific Tracks Abstracts: J Clin Exp Ophthalmol

Abstract :

Ophthalmic medications are often compounded by medical staff, nursing staff, or pharmacists because they are not commercially available. If these medications are not properly compounded, it can result in painful infections, loss of vision, or even loss of the eye. There are USP standards on how to prepare these compounded medications in a protected environment to ensure patient safety. In 2013, Congress passed the Drug Quality and Tracking Act to set legal standards for preparing and obtaining good quality compounded medications to prevent tragedies, such as the meningitis outbreak with NECC, endotoxin contamination causing toxic anterior segment syndrome, or fungal infections from compounded brilliant blue G intravitreal injections. This presentation provides an overview on how to properly and safely prepare quality ophthalmic preparations that meet standards within a practice setting. It also provides information on how to outsource compounding services to a qualified compounding pharmacy or outsourcing facility with a review of the new Drug Quality and Tracking Act.

Biography :

Ophthalmic medications are often compounded by medical staff, nursing staff, or pharmacists because they are not commercially available. If these medications are not properly compounded, it can result in painful infections, loss of vision, or even loss of the eye. There are USP standards on how to prepare these compounded medications in a protected environment to ensure patient safety. In 2013, Congress passed the Drug Quality and Tracking Act to set legal standards for preparing and obtaining good quality compounded medications to prevent tragedies, such as the meningitis outbreak with NECC, endotoxin contamination causing toxic anterior segment syndrome, or fungal infections from compounded brilliant blue G intravitreal injections. This presentation provides an overview on how to properly and safely prepare quality ophthalmic preparations that meet standards within a practice setting. It also provides information on how to outsource compounding services to a qualified compounding pharmacy or outsourcing facility with a review of the new Drug Quality and Tracking Act.